This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Results of four separate studies on the role of Bacille Calmette Guerin (BCG) vaccination in the control and elimination of tuberculosis show a reduction of that disease from 75% to 100% in various Chicago areas.
An exhibit at the American Academy of Pediatrics in New York by Sol Roy Rosenthal, MD, director of the Institute for Tuberculosis Research at the University of Illinois, and Philip G. Rettig, executive director of the Research Foundation, Chicago, was prepared as the result of studies conducted by the Cook County Hospital, the Chicago Board of Health, the Research Foundation, and the Institute for Tuberculosis Research, Chicago.
It was found that there were three major factors in overall control of the disease: lack of contact with virulent tubercle bacilli, noncrowded housing conditions, and BCG vaccination.
In studies where it was not possible to break contract with virulent tubercle bacilli or where housing was crowded, Rettig
Vaccine Seems Effective in Control And Elimination of Tuberculosis. JAMA. 1964;190(8):35. doi:10.1001/jama.1964.03070210115050
Customize your JAMA Network experience by selecting one or more topics from the list below.